The combination of a simple inverse prediction model with an optimized RT-qPCR protocol showed that our ALK test was superior to the break-apart FISH assay in a cohort of 58 FFPE NSCLC cases, composed of 51 surgical and 7 cytology specimens. This evidence concerns the gene ALK and non-small cell lung carcinoma.